MedTrace Logo

Late Onset Alzheimer's Disease

NCT05010603 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-05-18

No results posted yet for this study

Summary

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

Conditions

Interventions

GENETIC

Blood Draw

Collection of blood samples for genetic testing

OTHER

Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test

Memory Test

Sponsors & Collaborators

Principal Investigators

  • Richard P. Mayeux, MD, MSc · Columbia University

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-15
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05010603 on ClinicalTrials.gov